Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Transdermal delivery of cannabidiol with other active moieties including cannabinoids

a technology of cannabinoids and cannabinoids, which is applied in the direction of organic active ingredients, plant/algae/fungi/lichens ingredients, pharmaceutical non-active ingredients, etc., can solve the problems of reducing the bioavailability of cbd, limiting the rate of mass transfer of cbd through the skin, and the adhesive used in such known devices has typically limited the rate of mass transfer of cbd to the skin

Inactive Publication Date: 2018-03-22
REMY BIOSCIENCES INC
View PDF5 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Orally taken CBD is exposed to the gastric environment and liver, which metabolizes the medicine and thereby lowers its bioavailability.
However, known reservoir-style transdermal devices have used liquid carriers and / or hydrophobic rate-controlling membranes and carriers which have undesirably limited the rate of mass transfer of CBD through the skin.
In addition, certain known reservoir-style devices require an additional adhesive coated overlay to hold the device in place on the wearer's skin.
However, the adhesive used in such known devices has typically limited the rate of mass transfer of CBD to the skin.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Transdermal delivery of cannabidiol with other active moieties including cannabinoids
  • Transdermal delivery of cannabidiol with other active moieties including cannabinoids
  • Transdermal delivery of cannabidiol with other active moieties including cannabinoids

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0112]The effects of using a hydrophobic, porous membrane versus a hydrophilic, porous membrane (such as membrane 24) in reservoir transdermal device 20 are studied in this example. A mixture is formed by dissolving CBD powder in ethanol to yield a solution comprising 10 percent by weight CBD and 90 percent by weight ethanol. The backing 22 is an occlusive backing film (PE / PET from 3M). Hydroxy ethyl cellulose is added to the solution to yield a thixotropic preparation 27. A volume of 300 μL of the preparation is placed in the reservoir 26.

[0113]The skin adhesive 30 is a BIO PSA 7-4301 adhesive coated to a thickness of 15 g / m2 on side 36 of membrane 24. An overlay adhesive patch is placed over the reservoir which forms an island in the middle. The overlay assures adhesion of the reservoir to the skin. The device 20 is contacted with a human cadaver epidermis, and diffusion through the epidermis is measured using the Franz Diffusion Cell method.

[0114]In a first run, membrane 24 is a ...

example 2

[0115]The reservoir device 20 of Example 1 is used, but instead of using ethanol alone as the liquid carrier, a mixture of ethanol and water is used wherein the ethanol comprises 70 percent by weight of the ethanol / water mixture, and water comprises 30 percent by weight of the ethanol / water mixture. The amount of CBD by weight of the combination of CBD and ethanol / water is 5 percent, and the amount of ethanol / water is 91.5 percent. The gelling agent is hydroxyethylcellulose, which is present in an amount of about 3.5% by weight of the preparation 27. A first run is conducted in which the membrane is placed comprises CBD is present

[0116]The device 20 is contacted with a human cadaver epidermis, and diffusion through the epidermis is measured using the Franz Diffusion Cell method. In a first run, the hydrophilic, porous membrane 24 of Example 1 is used. In a second run, the membrane 24 is omitted so that CBD diffuses directly through the skin adhesive 30. The cumulative flux versus ti...

example 3

[0117]This example is conducted using three reservoir transdermal devices such as those of Example 1, with each having the hydrophilic, porous membrane described therein. In each case, the preparation includes a mixture of CBD and a liquid carrier with ten (10) percent CBD by weight of the CBD / liquid carrier mixture. Three runs are conducted, each with a device that includes a different liquid carrier in its preparation 27: 1, 2 propylene glycol, PEG-300, and oleic acid. Diffusion through a human cadaver epidermis is measured using the Franz Diffusion Method.

[0118]The cumulative flux versus time is plotted in FIG. 5. As the figure indicates, throughout the period, oleic acid provides a significantly better rate of transfer of CBD through the skin than either 1,2 propylene glycol or PEG-300.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
pore sizeaaaaaaaaaa
porosityaaaaaaaaaa
mean flow pore sizeaaaaaaaaaa
Login to View More

Abstract

Transdermal delivery devices for the delivery of cannabidiol (CBD) and related moieties are shown and described. In a reservoir-patch design, a microporous, hydrophilic membrane and a backing define a reservoir that houses a mixture of CBD, a polar liquid, and a gelling agent, along with other moieties that seem to be enhanced or bioavailability of increased by the same. The hydrophilic membrane is coated with an amine-compatible silicone skin adhesive. In a monolithic design, a release liner is coated with a mixture of CBD and a PIB or amine-compatible silicone skin adhesive laminated to the backing material. In using CBD as a pure compound or as one to combine with other moieties, the invention is able to control delivery better than the prior art. Construction of the Transdermal patch of reservoir type is also taught, which enables things such as Vitamin B 12 to become part of the complex deliverable by the inventions.

Description

CROSS REFERENCE TO RELATED APPLICATIONS[0001]The application is a Divisional of U.S. patent application Ser. No. 15 / 265,823, filed Sep. 14, 2016, which claims the benefit of, and priority to U.S. Provisional Patent Application No. 62 / 283,890 filed Sep. 14, 2015, the content of which is incorporated herein by reference herein in its entirety.FIELD[0002]This disclosure relates to devices and methods for the transdermal delivery of cannabidiol, among other desiderata using improved patch-technology, by way of a liquid saturated matrix and / or saturated alcohol solution.BACKGROUND[0003]Cannabidiol (CBD) (C21H30O2, CAS Registry No. 13956-29-1) is an active cannabinoid present in cannabis, a genus of flowering plants that includes Cannabis saliva, Cannabis indica, and Cannabis ruderalis. Other cannabinoids include tetrahydrocannabinol (THC), tetrahydrocarnabinolic acid (THC-a), cannabinol (CBN), and cannabichromene (CBC). Research shows that the combinations of various moieties produces mu...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K9/70A61K36/185A61K47/12A61K47/32A61K47/34A61K31/05A61K47/38A61K47/10A61K31/352
CPCA61K36/185A61K47/12A61K47/32A61K47/34A61K31/05A61K9/703A61K47/38A61K47/10A61K31/352A61K9/7053A61K9/7084
Inventor WEIMANN, LUDWIG
Owner REMY BIOSCIENCES INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com